Jobs / United States / Novartis Pharmaceuticals Corporation
Value & Access Head, ACC
Novartis Pharmaceuticals Corporation · 🇺🇸 Panama
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 75 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Novartis Pharmaceuticals Corporation
The US Department of Labor certified 75 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Novartis Pharmaceuticals Corporation →
About the role
Job Description Summary #LI-Hybrid Location: Panama The Country Value & Access (V&A) Head leads the development and execution of integrated access, pricing, HEOR/HTA, and healthcare system-shaping strategies to secure and sustain timely, equitable, and commercially viable patient access to Novartis innovations. The role ensures end-to-end access excellence across the portfolio, with a strong focus on priority Therapeutic Areas and key launches in large, complex healthcare systems. The role drives external partnerships, shapes the evolving healthcare ecosystem, and leads cross-functional collaboration to deliver compelling value propositions for payers, policymakers, providers, and patients. Job Description Key responsibilities • Lead the national access strategy for priority Therapeutic Areas and key assets, integrating commercial, medical, and public affairs priorities into actionable plans. • Represent the payer perspective in early pipeline and Target Product Profile discussions, assess access feasibility, and define long-term asset maximization and indication-sequencing strategies. • Identify healthcare-system and product-specific access hurdles and develop policy solutions that enable timely, sustainable access and best-in-class launches. • Build strategic partnerships with government bodies, payers, policymakers, hospitals, patient groups, private insurers, wholesalers, and other ecosystem stakeholders. • Co-create innovative healthcare solutions that improve patient access, affordability, and system sustainability while anticipating and shaping policy evolution. • Lead national pricing strategy, governance, research, scenario forecasting, tendering, contracting, and price and reimbursement negotiations, including innovative and outcomes-based agreements. • Lead HEOR/HTA strategy and integrated evidence planning, ensuring timely, high-quality submissions, value dossiers, economic models, budget-impact and cost-effectiveness analyses, and locally relevant evidence generation. • Provide strategic leadership to Access Field teams and cross-functional account planning, supporting early-access schemes, contracting execution, hospital listings, and healthcare-system readiness. • Ensure compliance with international pricing policies and provide strategic guidance on national access, negotiation frameworks, reimbursement submissions, and external engagement. • Build a high-performance culture by recruiting, coaching, developing, and retaining talent, strengthening succession pipelines, and role-modelling Novartis Leadership Expectations and Behaviors. Essential Requirements • University degree in Health Economics, Public Health, Life Sciences, Medicine, Pharmacy, Economics, or equivalent; 10+ years of experience in Market Access, HEOR, Pricing, Health Policy, or related disciplines. • Direct leadership experience managing large teams, with a demonstrated ability to engage, empower, coach, and develop talent. • Deep understanding of the local healthcare ecosystem, ideally complemented by exposure to other market archetypes or above-country experience. • Proven experience engaging government stakeholders, regulators, HTA agencies, payers, hospitals, and other healthcare-system partners. • Strong track record in pricing and reimbursement negotiations, innovative contracting, payer-strategy development, and compliance with pricing governance. • Experience co-creating healthcare solutions with external stakeholders at healthcare-system or disease-area level. • Demonstrated ability to represent the payer perspective in early pipeline shaping and clinical development discussions, supported by strong HEOR/HTA and evidence-planning expertise. • Strong cross-functional leadership across Commercial, Med